Category Health Tech

Prosegue l’inarrestabile diffusione commerciale di ACCED, il robot che da dieci anni domina il mercato francese e aumenta la sicurezza terapeutica

Deenova, leader in Europa nelle soluzioni di automazione per le farmacie ospedaliere con terapie in dose unitaria, ha annunciato oggi l’aggiudicazione di due gare competitive UniHA in Francia per tre dei suoi…

Read MoreProsegue l’inarrestabile diffusione commerciale di ACCED, il robot che da dieci anni domina il mercato francese e aumenta la sicurezza terapeutica

Con 10 años dominando el mercado Frances, ACCED, El Robot más seguro para la preparación y dispensación de medicamentos, continua su expansión comercial sin precedentes

Deenova, la compañía líder en Europa en el suministro de soluciones automatizadas para la producción de dosis unitarias en la farmacia hospitalaria anunció hoy la adjudicación de dos licitaciones competitivas UniHA (cooperativa…

Read MoreCon 10 años dominando el mercado Frances, ACCED, El Robot más seguro para la preparación y dispensación de medicamentos, continua su expansión comercial sin precedentes

IDEX Corporation Continues Strategic Capital Deployment with Agreement to Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric Optical Filters

IDEX Corporation (NYSE:IEX) today announced it has entered into a definitive agreement to acquire Iridian Spectral Technologies (“Iridian”) for cash consideration of 150 million Canadian dollars (“CAD”), subject to customary adjustments.…

Read MoreIDEX Corporation Continues Strategic Capital Deployment with Agreement to Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric Optical Filters

Lumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy

 A privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE) pivotal trial…

Read MoreLumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

Generate:Biomedicines and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced…

Read MoreGenerate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI